Cargando…

Inter-fractional monitoring of [Formula: see text] C ions treatments: results from a clinical trial at the CNAO facility

The high dose conformity and healthy tissue sparing achievable in Particle Therapy when using C ions calls for safety factors in treatment planning, to prevent the tumor under-dosage related to the possible occurrence of inter-fractional morphological changes during a treatment. This limitation coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischetti, M., Baroni, G., Battistoni, G., Bisogni, G., Cerello, P., Ciocca, M., De Maria, P., De Simoni, M., Di Lullo, B., Donetti, M., Dong, Y., Embriaco, A., Ferrero, V., Fiorina, E., Franciosini, G., Galante, F., Kraan, A., Luongo, C., Magi, M., Mancini-Terracciano, C., Marafini, M., Malekzadeh, E., Mattei, I., Mazzoni, E., Mirabelli, R., Mirandola, A., Morrocchi, M., Muraro, S., Patera, V., Pennazio, F., Schiavi, A., Sciubba, A., Solfaroli Camillocci, E., Sportelli, G., Tampellini, S., Toppi, M., Traini, G., Valle, S. M., Vischioni, B., Vitolo, V., Sarti, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693236/
https://www.ncbi.nlm.nih.gov/pubmed/33244102
http://dx.doi.org/10.1038/s41598-020-77843-z
_version_ 1783614697351675904
author Fischetti, M.
Baroni, G.
Battistoni, G.
Bisogni, G.
Cerello, P.
Ciocca, M.
De Maria, P.
De Simoni, M.
Di Lullo, B.
Donetti, M.
Dong, Y.
Embriaco, A.
Ferrero, V.
Fiorina, E.
Franciosini, G.
Galante, F.
Kraan, A.
Luongo, C.
Magi, M.
Mancini-Terracciano, C.
Marafini, M.
Malekzadeh, E.
Mattei, I.
Mazzoni, E.
Mirabelli, R.
Mirandola, A.
Morrocchi, M.
Muraro, S.
Patera, V.
Pennazio, F.
Schiavi, A.
Sciubba, A.
Solfaroli Camillocci, E.
Sportelli, G.
Tampellini, S.
Toppi, M.
Traini, G.
Valle, S. M.
Vischioni, B.
Vitolo, V.
Sarti, A.
author_facet Fischetti, M.
Baroni, G.
Battistoni, G.
Bisogni, G.
Cerello, P.
Ciocca, M.
De Maria, P.
De Simoni, M.
Di Lullo, B.
Donetti, M.
Dong, Y.
Embriaco, A.
Ferrero, V.
Fiorina, E.
Franciosini, G.
Galante, F.
Kraan, A.
Luongo, C.
Magi, M.
Mancini-Terracciano, C.
Marafini, M.
Malekzadeh, E.
Mattei, I.
Mazzoni, E.
Mirabelli, R.
Mirandola, A.
Morrocchi, M.
Muraro, S.
Patera, V.
Pennazio, F.
Schiavi, A.
Sciubba, A.
Solfaroli Camillocci, E.
Sportelli, G.
Tampellini, S.
Toppi, M.
Traini, G.
Valle, S. M.
Vischioni, B.
Vitolo, V.
Sarti, A.
author_sort Fischetti, M.
collection PubMed
description The high dose conformity and healthy tissue sparing achievable in Particle Therapy when using C ions calls for safety factors in treatment planning, to prevent the tumor under-dosage related to the possible occurrence of inter-fractional morphological changes during a treatment. This limitation could be overcome by a range monitor, still missing in clinical routine, capable of providing on-line feedback. The Dose Profiler (DP) is a detector developed within the INnovative Solution for In-beam Dosimetry in hadronthErapy (INSIDE) collaboration for the monitoring of carbon ion treatments at the CNAO facility (Centro Nazionale di Adroterapia Oncologica) exploiting the detection of charged secondary fragments that escape from the patient. The DP capability to detect inter-fractional changes is demonstrated by comparing the obtained fragment emission maps in different fractions of the treatments enrolled in the first ever clinical trial of such a monitoring system, performed at CNAO. The case of a CNAO patient that underwent a significant morphological change is presented in detail, focusing on the implications that can be drawn for the achievable inter-fractional monitoring DP sensitivity in real clinical conditions. The results have been cross-checked against a simulation study.
format Online
Article
Text
id pubmed-7693236
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-76932362020-11-30 Inter-fractional monitoring of [Formula: see text] C ions treatments: results from a clinical trial at the CNAO facility Fischetti, M. Baroni, G. Battistoni, G. Bisogni, G. Cerello, P. Ciocca, M. De Maria, P. De Simoni, M. Di Lullo, B. Donetti, M. Dong, Y. Embriaco, A. Ferrero, V. Fiorina, E. Franciosini, G. Galante, F. Kraan, A. Luongo, C. Magi, M. Mancini-Terracciano, C. Marafini, M. Malekzadeh, E. Mattei, I. Mazzoni, E. Mirabelli, R. Mirandola, A. Morrocchi, M. Muraro, S. Patera, V. Pennazio, F. Schiavi, A. Sciubba, A. Solfaroli Camillocci, E. Sportelli, G. Tampellini, S. Toppi, M. Traini, G. Valle, S. M. Vischioni, B. Vitolo, V. Sarti, A. Sci Rep Article The high dose conformity and healthy tissue sparing achievable in Particle Therapy when using C ions calls for safety factors in treatment planning, to prevent the tumor under-dosage related to the possible occurrence of inter-fractional morphological changes during a treatment. This limitation could be overcome by a range monitor, still missing in clinical routine, capable of providing on-line feedback. The Dose Profiler (DP) is a detector developed within the INnovative Solution for In-beam Dosimetry in hadronthErapy (INSIDE) collaboration for the monitoring of carbon ion treatments at the CNAO facility (Centro Nazionale di Adroterapia Oncologica) exploiting the detection of charged secondary fragments that escape from the patient. The DP capability to detect inter-fractional changes is demonstrated by comparing the obtained fragment emission maps in different fractions of the treatments enrolled in the first ever clinical trial of such a monitoring system, performed at CNAO. The case of a CNAO patient that underwent a significant morphological change is presented in detail, focusing on the implications that can be drawn for the achievable inter-fractional monitoring DP sensitivity in real clinical conditions. The results have been cross-checked against a simulation study. Nature Publishing Group UK 2020-11-26 /pmc/articles/PMC7693236/ /pubmed/33244102 http://dx.doi.org/10.1038/s41598-020-77843-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Fischetti, M.
Baroni, G.
Battistoni, G.
Bisogni, G.
Cerello, P.
Ciocca, M.
De Maria, P.
De Simoni, M.
Di Lullo, B.
Donetti, M.
Dong, Y.
Embriaco, A.
Ferrero, V.
Fiorina, E.
Franciosini, G.
Galante, F.
Kraan, A.
Luongo, C.
Magi, M.
Mancini-Terracciano, C.
Marafini, M.
Malekzadeh, E.
Mattei, I.
Mazzoni, E.
Mirabelli, R.
Mirandola, A.
Morrocchi, M.
Muraro, S.
Patera, V.
Pennazio, F.
Schiavi, A.
Sciubba, A.
Solfaroli Camillocci, E.
Sportelli, G.
Tampellini, S.
Toppi, M.
Traini, G.
Valle, S. M.
Vischioni, B.
Vitolo, V.
Sarti, A.
Inter-fractional monitoring of [Formula: see text] C ions treatments: results from a clinical trial at the CNAO facility
title Inter-fractional monitoring of [Formula: see text] C ions treatments: results from a clinical trial at the CNAO facility
title_full Inter-fractional monitoring of [Formula: see text] C ions treatments: results from a clinical trial at the CNAO facility
title_fullStr Inter-fractional monitoring of [Formula: see text] C ions treatments: results from a clinical trial at the CNAO facility
title_full_unstemmed Inter-fractional monitoring of [Formula: see text] C ions treatments: results from a clinical trial at the CNAO facility
title_short Inter-fractional monitoring of [Formula: see text] C ions treatments: results from a clinical trial at the CNAO facility
title_sort inter-fractional monitoring of [formula: see text] c ions treatments: results from a clinical trial at the cnao facility
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693236/
https://www.ncbi.nlm.nih.gov/pubmed/33244102
http://dx.doi.org/10.1038/s41598-020-77843-z
work_keys_str_mv AT fischettim interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT baronig interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT battistonig interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT bisognig interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT cerellop interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT cioccam interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT demariap interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT desimonim interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT dilullob interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT donettim interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT dongy interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT embriacoa interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT ferrerov interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT fiorinae interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT franciosinig interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT galantef interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT kraana interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT luongoc interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT magim interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT manciniterraccianoc interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT marafinim interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT malekzadehe interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT matteii interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT mazzonie interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT mirabellir interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT mirandolaa interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT morrocchim interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT muraros interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT paterav interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT pennaziof interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT schiavia interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT sciubbaa interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT solfarolicamilloccie interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT sportellig interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT tampellinis interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT toppim interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT trainig interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT vallesm interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT vischionib interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT vitolov interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility
AT sartia interfractionalmonitoringofformulaseetextcionstreatmentsresultsfromaclinicaltrialatthecnaofacility